BioNTech Retained Earnings from 2010 to 2025

BNTX Stock

USD 97.39 0.34 0.35%

BioNTech Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings are likely to outpace its year average in 2025. Retained Earnings is the cumulative amount of net income that BioNTech SE retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2018-12-31

Previous Quarter

18.9 B

Current Value

19.1 B

Quarterly Volatility

9 B

Covid

Check BioNTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioNTech's main balance sheet or income statement drivers, such as Net Interest Income of 446.2 M, Interest Income of 459.5 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 9.02, Dividend Yield of 0.011 or PTB Ratio of 1.41. BioNTech financial statements analysis is a perfect complement when working with BioNTech Valuation or Volatility modules.

Check out the analysis of BioNTech Correlation against competitors.

Latest BioNTech's Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of BioNTech SE over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. BioNTech's Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioNTech's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 19.1 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

BioNTech Retained Earnings Regression Statistics

	Arithmetic Mean	5,347,963,750
	Coefficient Of Variation	163.92
	Mean Deviation	7,611,285,156
	Median	(112,100,000)
	Standard Deviation	8,766,292,712
	Sample Variance	76847887.9T
	Range	20.5B
	R-Value	0.81
	Mean Square Error	28884106.3T
	R-Squared	0.65
	Significance	0.0002
	Slope	1,483,577,582
	Total Sum of Squares	1152718318.8T

BioNTech Retained Earnings History

	2025	20.1 B
	2024	19.1 B
	2023	19.8 B
	2022	18.8 B
	2021	9.9 B
	2020	-409.6 M
	2019	-424.8 M

Other Fundumenentals of BioNTech SE

Retained Earnings Total Equity

BioNTech Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Long Term Investments	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	0.59	-0.93	0.99	0.93	0.62	0.84	0.78	0.9	0.79	0.95	0.62	0.84	0.7	0.96	0.96	0.86
Total Stockholder Equity	1.0		0.58	-0.94	1.0	0.94	0.58	0.85	0.79	0.88	0.81	0.94	0.58	0.85	0.69	0.96	0.96	0.85
Current Deferred Revenue	0.59	0.58		-0.5	0.56	0.7	0.23	0.69	0.6	0.58	0.62	0.56	0.32	0.69	0.74	0.59	0.56	0.79
Net Debt	-0.93	-0.94	-0.5		-0.95	-0.85	-0.4	-0.77	-0.7	-0.75	-0.74	-0.9	-0.37	-0.78	-0.61	-0.93	-0.92	-0.76
Retained Earnings	0.99	1.0	0.56	-0.95		0.94	0.54	0.87	0.81	0.86	0.83	0.93	0.54	0.87	0.66	0.95	0.95	0.83
Accounts Payable	0.93	0.94	0.7	-0.85	0.94		0.38	0.97	0.94	0.76	0.94	0.81	0.43	0.96	0.71	0.85	0.83	0.88
Net Receivables	0.62	0.58	0.23	-0.4	0.54	0.38		0.19	0.12	0.84	0.11	0.69	0.98	0.19	0.49	0.61	0.65	0.5
Good Will	0.84	0.85	0.69	-0.77	0.87	0.97	0.19		0.98	0.62	0.99	0.69	0.25	1.0	0.58	0.76	0.72	0.79
Short Term Investments	0.78	0.79	0.6	-0.7	0.81	0.94	0.12	0.98		0.53	0.99	0.6	0.18	0.97	0.51	0.67	0.63	0.74
Total Liab	0.9	0.88	0.58	-0.75	0.86	0.76	0.84	0.62	0.53		0.54	0.95	0.85	0.62	0.71	0.93	0.94	0.81
Long Term Investments	0.79	0.81	0.62	-0.74	0.83	0.94	0.11	0.99	0.99	0.54		0.63	0.16	0.99	0.51	0.7	0.67	0.73
Total Current Assets	0.95	0.94	0.56	-0.9	0.93	0.81	0.69	0.69	0.6	0.95	0.63		0.67	0.7	0.69	0.99	1.0	0.81
Short Term Debt	0.62	0.58	0.32	-0.37	0.54	0.43	0.98	0.25	0.18	0.85	0.16	0.67		0.25	0.56	0.6	0.64	0.56
Intangible Assets	0.84	0.85	0.69	-0.78	0.87	0.96	0.19	1.0	0.97	0.62	0.99	0.7	0.25		0.63	0.76	0.73	0.79
Common Stock	0.7	0.69	0.74	-0.61	0.66	0.71	0.49	0.58	0.51	0.71	0.51	0.69	0.56	0.63		0.7	0.69	0.85
Net Invested Capital	0.96	0.96	0.59	-0.93	0.95	0.85	0.61	0.76	0.67	0.93	0.7	0.99	0.6	0.76	0.7		1.0	0.83
Net Working Capital	0.96	0.96	0.56	-0.92	0.95	0.83	0.65	0.72	0.63	0.94	0.67	1.0	0.64	0.73	0.69	1.0		0.81
Capital Stock	0.86	0.85	0.79	-0.76	0.83	0.88	0.5	0.79	0.74	0.81	0.73	0.81	0.56	0.79	0.85	0.83	0.81

Click cells to compare fundamentals

About BioNTech Financial Statements

BioNTech investors use historical fundamental indicators, such as BioNTech's Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioNTech. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Retained Earnings	19.1 B	20.1 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC